myeloid leukemia

(redirected from myelogenous leukemia)
Also found in: Thesaurus, Medical, Encyclopedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.myeloid leukemia - chronic leukemia characterized by granular leukocytes; more common in older people
chronic leukemia - slowly progressing leukemia
granulocytic leukemia, myelocytic leukemia - a malignant neoplasm of blood-forming tissues; marked by proliferation of myelocytes and their presence in the blood
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
Summary: Chronic Myelogenous Leukemia (CML) takes place when the bone marrow starts making too many white blood cells.
Alexander Hoischen, PhD, from Radboud University Medical Center in the Netherlands, will provide an update on their study comparing Bionano optical mapping with Saphyr to the current clinical testing workflows for Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia among other hematologic malignancies and some genetic disorders.
According to the company, Busulfan Injection is indicated for use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia.
8, 2008, Francis was diagnosed with acute myelogenous leukemia (AML), which is a type of cancer in the blood and bone marrow.
Request Free Sample Report @ https://www.mrrse.com/sample/4051 Chronic Myelogenous Leukemia (CML) takes place when the bone marrow starts making too many white blood cells.
Busulfan is used in combination with cyclophosphamide in the treatment of chronic myelogenous leukemia.
The company's attorney admitted in the court filings that scientific literature has established an association between high-dose, chronic benzene exposure and development of certain forms of acute myelogenous leukemia, but denied Bugarin-Mathews' disease was caused by benzene exposure.
Chronic Myelogenous Leukemia (CML) usually presents in chronic phase, followed by an accelerated phase and a blast phase, if untreated.
Philadelphia chromosome is found in most patients with chronic myelogenous leukemia (CML) and sometimes also in acute lymphoblastic leukemia and acute myelogenous leukemia.
Prior to that, he was responsible for teams at BMS that advanced more than 20 compounds into clinical development including SPRYCEL (dasatinib) for the treatment of chronic myelogenous leukemia, which he co-invented.